Search results
IRLAB: Invitation to the Interim Report for Q2 2024 Presentation and Webcast
Digital Journal· 15 hours agoFor more information Gunnar Olsson, CEO Phone: +46 70 576 14 02 E-mail: gunnar.olsson@irlab.se Viktor Siewertz, CFO Phone: +46 727 10 70 70 E-mail: viktor.siewertz ...
IRLAB's Phase IIb Study of Pirepemat Can Proceed as Planned after Positive Opinion from External...
Digital Journal· 7 days agoAbout IRLAB IRLAB discovers and develops a portfolio of transformative treatments for all stages of Parkinson's disease. The company originates from Nobel Laureate Prof Arvid Carlsson ...